To date, no study has prospectively compared open versus robotic radical prostatectomy in a randomized fashion for patients with prostate cancer. For patients with newly diagnosed prostate cancer who choose surgical management, the choice of surgical approach is often limited to surgeon preference and experience. This study will prospectively randomize patients with localized prostate cancer who are candidates for surgical management to open versus robotic radical prostatectomy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
10
Robotic assisted radical prostatectomy
Open radical prostatectomy
Mayo Clinic
Rochester, Minnesota, United States
Trifecta
Free from biochemical recurrence, continent, and potent 2 years after radical prostatectomy
Time frame: at 2 years
Continence
Continent of urine
Time frame: at 3, 12, and 24 months
Potency
Satisfactory erections
Time frame: at 3, 12, and 24 months
Free from biochemical recurrence
PSA \<0.2 ng/mL
Time frame: at 3, 12, and 24 months
Acute complications
Any complication according to Calvien classification
Time frame: Within 30 days of surgery
Long-term complication
bladder neck contracture, lymphocele
Time frame: >30 days
Estimated blood loss
Time frame: Participants will be followed for the duration of the operation, an expected average of 3 hours
Operative time
Time frame: Participants will be followed for the duration of the operation, an expected average of 3 hours
Length of hospital stay
Time frame: Participants will be followed for the duration of the hospital stay, an expected average of 1-2 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.